Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 785, February 1, 2009. Published Online First January 20, 2009;
doi: 10.1158/0008-5472.CAN-08-1946
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-08-1946v1
69/3/785    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castellana, D.
Right arrow Articles by Kunzelmann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castellana, D.
Right arrow Articles by Kunzelmann, C.

Cell, Tumor, and Stem Cell Biology

Membrane Microvesicles as Actors in the Establishment of a Favorable Prostatic Tumoral Niche: A Role for Activated Fibroblasts and CX3CL1-CX3CR1 Axis

Donatello Castellana1,2, Fatiha Zobairi1, Maria Carmen Martinez3, Maria Antonietta Panaro2, Vincenzo Mitolo2, Jean-Marie Freyssinet1 and Corinne Kunzelmann1,4

1 U770 Institut National de la Sante et de la Recherche Medicale (INSERM), Le Kremlin-Bicêtre, France; Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France; Université Louis Pasteur, Faculté de Médecine, Strasbourg, France; 2 University of Bari, Faculty of Medicine, Dipartimento di anatomia umana e di istologia, Policlinico, Bari, Italy; 3 INSERM U771 CNRS Université d'Angers, Faculté de Médecine, Angers, France; and 4 Hôpitaux Universitaires de Strasbourg, Service d'Hématologie Biologique, Hôpital de Hautepierre, Strasbourg, France

Requests for reprints: Corinne Kunzelmann, Institut National de la Sante et de la Recherche Medicale U770, Université Louis Pasteur, Faculté de Médecine, Institut d'Hématologie et d'Immunologie, 4 rue Kirschleger, F-67085 Strasbourg, France. Phone: 33-390-24-3987; Fax: 33-390-24-4016; E-mail: Corinne.Kunzelmann{at}hemato-ulp.u-strasbg.fr.

Key Words: microvesicles • tumoral niche • CX3CR1 • microenvironment • fibroblasts

Tumor microenvironment is enriched in plasma membrane microvesicles (MV) shed from all cell types that constitute the tumor mass, reflecting the antigenic profile of the cells they originate from. Fibroblasts and tumor cells mutually communicate within tumor microenvironment. Recent evidences suggest that tumor-derived MVs (TMV) exert a broad array of biological functions in cell-to-cell communication. To elucidate their role in cancer-to-fibroblast cell communication, TMV obtained from two prostate carcinoma cell lines with high and weak metastatic potential (PC3 and LnCaP, respectively) have been characterized. TMV exhibit matrix metalloproteinases (MMP) and extracellular MMP inducer at their surface, suggesting a role in extracellular matrix degradation. Moreover, TMV not only induce the activation of fibroblasts assessed through extracellular signal-regulated kinase 1/2 phosphorylation and MMP-9 up-regulation, increase motility and resistance to apoptosis but also promote MV shedding from activated fibroblasts able in turn to increase migration and invasion of highly metastatic PC3 cells but not LnCaP cells. PC3 cell chemotaxis seems, at least partially, dependent on membrane-bound CX3CL1/fractalkine ligand for chemokine receptor CX3CR1. The present results highlight a mechanism of mutual communication attributable not only to soluble factors but also to determinants harbored by MV, possibly contributing to the constitution of a favorable niche for cancer development. [Cancer Res 2009;69(3):785–93]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.